Baird Financial Group
RXRX icon

Baird Financial Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Baird Financial Group’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,498
Closed -$76.7K – 1844
2025
Q1 		$76.7K Buy
14,498
+203
+1% +$1.07K ﹤0.01% 1731
2024
Q4 		$96.6K Sell
14,295
-179
-1% -$1.21K ﹤0.01% 1723
2024
Q3 		$95.4K Buy
+14,474
New +$95.4K ﹤0.01% 1710